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ABSTRACT
Background: This study compares results of endome-
trial ablation alone and in combination with myoma
coagulation. Subsequent surgery rates were 38% for
ablation alone and 12% for combined therapy.
Objective: The purpose of this study was to compare
hysterectomy rates following various surgical procedures
to treat profuse uterine bleeding as well as myomatous
uteri.
Study Design: This is a descriptive study of women
who underwent endometrial ablation alone, endometrial
ablation with myoma coagulation, or endometrial resec-
tion with myoma coagulation to treat profuse uterine
bleeding as well as myomatous uterus. From 1986 to
1995, the author performed 52 endometrial ablation pro-
cedures; 88 myoma coagulation and endometrial ablation
procedures; and 28 myoma coagulations with resection
of submucous myomas in patients who were subse-
quently available for follow-up. Patients were followed
up for up to ten years.
Results: Of the patients undergoing ablation alone, 20
(38%) of 52 required a second surgery for continued
symptoms during a mean follow-up of 47 months. Five
of these patients (9.6%) underwent hysterectomy. Of the
patients who underwent endometrial ablation plus
myoma coagulation (myolysis), 11 (12.5%) of 88 required
a repeat surgical procedure during a mean follow-up of
25 months. Five of these patients (5.7%) underwent hys-
terectomy. Volumetric measurements revealed an aver-
age reduction in fibroid volume of 54.5% in this patient
group following treatment with a gonadotropin-releasing
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hormone (GnRH) agonist and combined myoma coagu-
lation and endometrial ablation surgery. Of the 28
patients who underwent myoma coagulation plus resec-
tion, five (18%) required a repeat procedure. Of these
five, one (4%) required hysterectomy. Fibroid volume in
this group was reduced by a mean of 72.6% following
administration of a GnRH agonist and combined laparo-
scopic and hysteroscopic surgery as described. The rate
of reoperation was significantly lower among patients
receiving endometrial ablation with myoma lysis with or
without resection compared with those undergoing
endometrial ablation alone (P<0.01).
Conclusions: Myoma coagulation (myolysis), when
combined with endometrial ablation among women with
symptomatic fibroids and bleeding, reduces all subse-
quent surgery rates compared with endometrial ablation
alone. Myolysis with endometrial resection also results
in a reduced need for hysterectomy.
Key Words: Fibroids, Uterine bleeding, Endometrial
ablation, Myoma coagulation, Endometrial resection,
Hysterectomy.
INTRODUCTION
Approximately 750,000 hysterectomies are performed in
the United States each year, with a mortality rate of about
12 per every 10,000 hysterectomies performed.
1 Costs to
consumers and insurers have been estimated at approxi-
mately $1.7 billion per year.
2 Thus, alternative proce-
dures that are safer and less invasive, preserve the uterus,
and have less of an economic cost are increasingly in
demand. In recent years, several such techniques have
been introduced.
Endometrial ablation was first performed in 1981 by
Goldrath and colleagues using the Nd:YAG laser.
3
Vancaille subsequently published a report of rollerball
ablation in 1989.
4 Amenorrhea rates following ablation
have been 25% to 84%,
3,5-1
4 with patient satisfaction rates
up to 80% at one year.
6,7,1
5 However, a recent study by
Unger and Meeks
1
6 indicates that as many as 34% of
women require hysterectomy within five years of abla-
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Table 1.
Comparison of outcomes following three procedures.
Mean follow-up
Menstrual outcome
Amenorrhea
Continued heavy bleeding
% who underwent
2nd procedures for
any reason
% hysterectomies
Ablation alone
(n=52)
about 4 years
36.5%
38%
38%
9.6%
Ablation + Myolysis
(n=88)
about 2 years
57%
6.8%
12.5%
5.7%
Resection + Myolysis
(n=29)
nearly 3 years
18%
14%
18%
3.5%
tion, and that this number increases with time. Multiple
procedures are likely to increase, rather than decrease,
morbidity and costs associated with hysterectomy.
In 1990, Goldfarb first reported the technique of myoma
coagulation (myolysis) in the United States.
1
7 Myoma
coagulation was first performed with the Nd:YAG laser.
1
8
In 1992, the technique was altered by the use of a 5 cm
modified bipolar needle (manufactured by B. Resnick &
Company, Skokee, IL, and J.E.M.D. Medical, Hicksville,
Long Island, NY) to pierce myomas using bipolar current
at 50 to 75 watts.
1
9
Since the introduction of myolysis in 1990, the procedure
has been combined with endometrial ablation in patients
with symptomatic fibroids who also exhibit persistent
recurrent uterine bleeding refractory to medical therapy.
It was hypothesized that this combination procedure
would further reduce rates of subsequent hysterectomy
or other surgeries.
This study compares subsequent reoperation rates in a
cohort of three patient groups: 1) those who underwent
endometrial ablation alone prior to 1990, 2) patients who
underwent endometrial ablation with myoma coagula-
tion, and 3) women who underwent endometrial resec-
tion for submucosal myomas with myoma coagulation.
After 1990, all of the women in the latter two groups were
treated for profuse uterine bleeding with fibroids. Prior
to 1990, only endometrial ablation was available as a
treatment modality; the majority of the women treated
with ablation alone at this time had fibroid uterus as well
as severe uterine bleeding. Subsequent rates of hys-
terectomy as well as repeat surgical procedures for these
three patient groups are evaluated, and menstrual out-
come and surgical complications are also tabulated.
MATERIAL AND METHODS
All patients who presented between 1986 and 1990 with
complaints of profuse uterine bleeding and wishing to
preserve their uterus were considered for endometrial
ablation. Most of these patients also had uterine fibroids.
Between 1990 and 1995, patients with both profuse uter-
ine bleeding and fibroids and no desire for future child-
bearing were considered for myoma coagulation with
endometrial resection or ablation, depending upon the
location of myomas. (Patients with submucosal myomas
underwent resection; all others underwent ablation.)
All patients received a preoperative evaluation consisting
of medical history, physical, and pelvic examination, as
well as abdominal and vaginal ultrasound scan, endome-
trial biopsy, and hysteroscopy to determine uterine
pathology.
2
0 Patients were considered possible surgical
candidates if the endometrial biopsy revealed no hyper-
plastic tissue, they had fibroids measuring no more than
10 cm, and they had active menstrual function.
Patients meeting these criteria and providing informed
consent were given a trial of gonadotropin-releasing hor-
mone (GnRH) agonist in depot form 10 to 14 weeks prior
to surgery as a therapeutic test. Surgery was conducted
only in patients who had a good response to the GnRH
agonist (ie, the symptoms disappeared and myoma vol-
ume was reduced 30% to 40%).
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The incidence of subsequent hysterectomies for women who had undergone one of three surgical procedures initially:
ablation alone, myolysis-ablation, or myolysis-resection.
Outcome
Subsequent
hysterectomy
No subsequent
hysterectomy
Combined
x
2 (2,N=168).
Ablation only
5 (9.6%)
47 (90.4%)
52
Myolisis + ablation
5 (57%)
83 (94.3%)
88
Myolisis + resection
1 (3.6%)
27 (96.4%)
28
Combined
11 (6.5%)
157 (93.5%)
168
Various endometrial ablation techniques were employed,
including the Nd:YAG laser and resectoscope techniques.
These techniques have been described elsewhere.
6,2
1
Myoma coagulation was performed using either the
Nd:YAG laser or bipolar needles, as previously
described. 19,22,23 Resection was also performed as previ-
ously described.
1
0
To maintain postoperative cavity patency, an endocervi-
cal and uterine endosuction was performed one month
after surgery. In addition, amenorrheic patients were
encouraged to return bi-yearly for vaginal ultrasounds to
ensure that hematometra was not present. Patients who
did not return for at least one postoperative follow-up
visit after the initial one-month visit for endosuction were
considered lost to follow-up.
The primary end point of this study was the requirement
for subsequent surgery related to inadequate relief of
symptoms following the initial procedure. In addition,
menstrual outcome and complication rates were assessed
in all groups.
Data on fibroid volume were obtained in select patients
who underwent the combination procedures. In these
patients, fibroids were measured pre- and postoperative-
ly in three dimensions transvaginally and abdominally
via ultrasound. To determine the volume of the leiomy-
oma, the following equation was used: 0.523(dimension
l)x(dimension 2)x(dimension 3).
2
4 A total of all the mea-
sured volumes was calculated for each group, and an
average volume was obtained for the initial and postop-
erative ultrasounds. Based on these figures, an average
percent reduction was computed for each group.
RESULTS
Ablation Alone Group
Of 72 patients who underwent endometrial ablation
alone, 20 (28%) were lost to follow-up. The remaining
52 patients were followed up for an average of 47
months (range, 2 months to 105 months). Mean age at
the time of surgery was 44 years, and mean parity was
1.87 children.
Nineteen patients (36.5%) became amenorrheic following
the initial endometrial ablation. Twelve patients (23%)
had subsequent bleeding within the normal range. Thus,
approximately 59% experienced improvement in bleed-
ing severity. Twenty women (38%) had continued heavy
bleeding requiring subsequent surgery. Two patients
(3.8% of the total group) required more than one subse-
quent surgery. Five patients (9.6%) underwent hysterec-
tomy.
Complications of endometrial ablation were as follows:
Twelve patients (16.6%) developed urinary tract infec-
tions. One patient (1.4%) became pregnant 17 months
after the surgery. This patient subsequently underwent
termination of pregnancy and tubal sterilization with no
subsequent bleeding problem. Back and pelvic pain
were experienced by one patient each (1.4% for each).
Serious complications were experienced by four patients
(5.5%) and included pulmonary congestion, hypona-
tremia, and degenerating myoma; fever, endometritis,
and bleeding at one month postablation; uterine and
intestinal perforation secondary to attempted fundal sub-
mucosal resection early in the series (repaired by laparo-
tomy); and peritonitis, hyponatremia, fluid overload and
pleural effusion.
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Table 3.
The incidence of any surgery, including hysterectomy, subsequent to one of three procedures initially:
ablation only, myolysis-ablation, or myolysis-resection.
Outcome
Subsequent
surgery of
some kind
No subsequent
surgery
Combined
x
2 (2N=168).
Ablation only
20 (38.5%)
32 (61.5%)
52
Myolisis + ablation
11 (12.5%)
83 (87.5%)
88
Myolisis + resection
3 (10.7%)
25 (89.3%)
28
Combined
36 (21.4%)
132 (78.6%)
168
Myolysis and Ablation Group
Of the 119 patients who underwent myolysis and
endometrial ablation, 31 (26%) were lost to follow-up,
and the remaining 88 women were followed up for a
mean of 25 months (range, 4 to 65 months). Mean age
at the time of surgery was 45 years, and mean parity was
1.35 children.
Following surgery, 50 patients (57%) became amenorrhe-
ic, and 32 (36%) patients had normal levels of menstrual
bleeding following surgery. Six patients (7%) had con-
tinued heavy bleeding. Eleven (12.5%) patients elected
to undergo subsequent procedures due to inadequate
control of symptoms with myoma coagulation plus
endometrial ablation. Five of these patients (5.7% of the
total evaluable group) underwent hysterectomy. The
other procedures included laparoscopic myomectomy (1
patient); repeat ablation due to pain, hematometria
and/or fibroid growth (4 patients); and myomectomy per-
formed hysteroscopically to remove a prolapsed fibroid
(1 patient).
Volumetric analysis was performed in 30 patients (34%).
In 30 patients, preoperative fibroid size ranged from 12 to
630 cm
3, with a mean of 230 cm
3 and a median of 205
cm
3. Following treatment with the GnRH agonist and
surgery, fibroids ranged in size from 3 to 483 cm
3, with a
mean and median of 103 and 81 cm
3, respectively. The
30 patients experienced an average 54.5% reduction in
fibroid size, with half the group experiencing reduction
in fibroid volume of at least 68%.
Complications occurred in 14 of the 88 évaluable patients
(15.9%), and included hematometra (5 patients, 5.7%);
fever (4 patients, 4.5%); urinary tract infection (2 patients,
2.3%); perforated bladder (1 patient, 1.1%); bacteremia (1
patient, 1.1%); and fibroid prolapse (1 patient, 1.1%).
Resection plus Myolysis Group
Forty-five patients with submucosal myomas underwent
resection and myolysis, of whom 17 (37%) were lost to
follow-up; endometrial ablation by the remaining 28
were followed for a mean of 33 months (range, 3 to 77
months). Mean age at the time of surgery was 43 years,
and the women had a mean of 2.0 children.
Following the surgery, four women (14%) experienced
continued heavy bleeding. Five (18%) developed amen-
orrhea. The remaining 19 (68%) had normal menstrual
bleeding postoperatively. Five patients (18%) underwent
subsequent surgery due to inadequate symptom relief.
One of these patients (3.5%) underwent hysterectomy.
Of the other four patients, one underwent a repeat abla-
tion and coagulation for hematometra; another received
hysteroscopy and lysis of adhesions; the third required
repeat resection, laparoscopic myomectomy, and bilater-
al salpingectomy for myoma degeneration and continued
heavy bleeding; and the fourth patient required repeat
endometrial coagulation and hysteroscopic resection of a
submucosal leiomyoma.
Volumetric analysis of fibroid volume was conducted in
13 patients (46%). Preoperative fibroid volumes ranged
from 30 to 363 cm
3, with a median of 111 cm
3 and a
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Table 4.
A survival analysis on the yearly incidence of subsequent hysterectomy for women
who had undergone one of three procedures initially: ablation only, myolysis-ablation, or myolysis-resection.
Initial surgical
procedure
Ablation alone
Myolysis-ablation
Myolysis-resection
Yearly proportions of subsequent hysterectomies
Number of years after initial surgery
n
52
88
28
1
.043
.025
.000
2
.029
.033
.000
3
.036
.000
.000
4
.043
.044
.000
5
.000
.000
.000
6
.000
.000
.333
7
.000
—
—
8
.000
—
—
9
.000
—
—
10
.000
—
—
Note: The differences among the survival rates for the three surgical procedures were not statistically significant using the Wilcoxon-
Gehan statistic.
Note: Since the two procedures involving myolysis were not used until 1990, the maximum time for follow-up data for these proce-
dures was six years.
mean of 152 cm
3. Following treatment with the GnRH
agonist and surgery, all patients experienced a reduction
in fibroid size. Postoperative fibroid volumes ranged
from 1 to 73 cm
3, with a median and mean of 36 and 35
cm
3, respectively. Half of the patients experienced a
reduction in fibroid volume of at least 83%. The entire
group experienced an average reduction of 72.6%.
Of the 28 évaluable patients in this group, only two (7%)
experienced surgical complications. One patient devel-
oped a pelvic infection and the other experienced uter-
ine perforation during surgery.
Comparing the Three Groups
The incidence of hysterectomy was rather infrequent
when the three procedures were combined (11 of 168 =
6.5%). The incidence in the ablation alone group (5 of
52 = 9.6%) was slightly higher compared with the two
myolysis groups (6 of 116 = 5.2%). When all subsequent
surgical procedures including hysterectomy were evalu-
ated, the incidence in the ablation group (20 of 52 =
38.5%) was significantly higher than in the myolysis-abla-
tion group (11 of 88 = 12.5%) or myolysis and resection
group (5 of 28 = 17.9%) (X
2 N = 168 = 13.34 p <0.01).
These outcomes are shown in Tables 1-3.
Survival analyses were carried out for both possible end
points [hysterectomies (Table 4) and subsequent surgical
procedures (Table 5)], in order to observe the yearly
incidence rates for the different surgical procedures and
to determine if there were differences between them.
The incidence of hysterectomies in the ablation-only
group appeared to be fairly uniform over the first four
years, at roughly 4% yearly. The rates in the myolysis-
ablation group also appeared fairly uniform; roughly
2.5% yearly. (The difference between these two rates is
not statistically significant.) There were insufficient data
from the myolysis-resection group to allow them to be
meaningfully included in the survival analysis, since only
one in 28 women in this condition required a hysterec-
tomy. This hysterectomy was performed during the
patient's fifth year.
When Life Table analysis was carried out using all sub-
sequent surgical procedures as the end point (Table 5),
the difference between ablation alone and the myolysis-
ablation was striking. For ablation only, the yearly rate
was roughly 10% for at least nine years, whereas for
myolysis ablation the yearly rate was only 3% for the first
three years. These analyses correct for length of partici-
pation and confirm that the difference between ablation
only and myolysis and ablation is significant (p<0.05).
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Table 5.
A survival analysis on the yearly incidence of subsequent surgeries of any kind for women
who had undergone one of three procedures initially: ablation only, myolysis-ablation, or myolysis-resection.
Initial surgical
procedure
Ablation alone
Myolysis-ablation
Myolysis-resection
Yearly proportions of subsequent hysterectomies
Number of years after initial surgery
n
52
88
28
1
.124
.037
.071
2
.110
.033
.044
3
.070
.026
.000
4
.122
.167
.111
5
.051
.000
.000
6
.069
.250
.333
7
.095
—
—
8
.133
—
—
9
.222
—
—
10
.000
—
—
Note: The differences among the survival rates for the ablation only procedure vs myolysis-resection was statistically significant using
the Wilcoxon-Gehan statistic, P<0.05.
Note: Since the two procedures involving myolysis were not used until 1990, the maximum time for follow-up data for these proce-
dures was six years.
COMMENT
In a series of 52 évaluable patients who underwent abla-
tion alone, 38% required at least one repeat surgery. Two
of these patients had more than one subsequent surgery.
The hysterectomy rate was 9.6%. If follow-up data for
the past six years only is considered, (the length of fol-
low-up available for the myolysis group also), only three
of the women in the ablation-only group had hysterecto-
my beyond the sixth year. The chi square analysis
remains unchanged, however, with the significance still
<0.05.
In a similar series of patients treated with rollerball
endometrial ablation by Unger and Meeks,
1
6 14 of 41
women (34%) underwent hysterectomy within 5 years of
the surgery. (No other types of repeat surgeries were
permitted according to their study protocol.) They
reported that the decision to undergo hysterectomy fol-
lowing ablation was associated with continued abnormal
bleeding and menstrual pain as well as gross abnormali-
ties such as uterine myomas. Seven (70%) of ten women
with severe menstrual pain and probable adenomyosis
underwent hysterectomy. In addition, 14 of the women
who had hysterectomy had significant pelvic disease: ten
had myomas, adenomyosis, or endometriosis. Unger and
Meeks also reported a linear relationship between hys-
terectomy and time, projecting that all of their ablation
patients would undergo hysterectomy within 13 years of
the initial procedure.
A comparison of the current data with those of Unger
and Meeks is provided in Table 6. In the current series,
the majority of patients undergoing ablation and all
patients in the myolysis group had uterine fibroids.
Resection was performed when submucosal myomas
required significant resculpturing of the endometrial cav-
ity.
An important point to consider is the motivation of
patients and physician. Those patients with continued
symptoms (bleeding) most often had migration of intra-
mural myomas or submucosal myomas to the uterine or
submucosal areas. In the current study, these patients
were offered repeat ablation or resection and even
myomectomy as an alternative to hysterectomy and were
encouraged to choose their most desired solution. This
contrasts with the series by Unger and Meeks in which
only hysterectomy was offered as a second procedure.
Unger and Meeks also noted that because the uterine
cavity may be scarred by the procedure and no longer
patent with the vagina, any subsequent menstrual flow
may be forced into the fallopian tubes causing pain and
endometriosis. In this study, cavity patency was main-
tained by performing an endometrial endosuction one
month after surgery; also, amenorrheic patients were fol-
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Table 6.
Comparison of ablation data.
n
Diagnosis
Mean age
Mean parity
Geographic demographic
Ablation technique
Lost to follow-up
Subsequent procedures*
of any type
hysterectomies*
Amenorrhea
Continued heavy bleeding
Serious complications
Goldfarb
72
Severe menorrhagia with or without fibroids
43.5 years
1.87 children
New Jersey
Various
28%
38% (w/in mean app. 4 years)
9.6% (w/in mean app. 4 yrs)
36.5%
20/52 (38%)
5.5%
Unger & Meeks
42
Severe menorrhagia with no other
gynecologic abnormality
40 years
2.5 children
Wisconsin
Rollerball
2.3%
34% (within 5 years)
not reported
8/41 (19.5%)
None
*In Goldfarb, subsequent procedures included repeat ablation, curettage, myoma coagulation, hysterectomy, and others. In Unger,
second-line surgical strategies were limited to hysterectomy.
lowed with bi-yearly vaginal ultrasound examination to
ensure that hematometra had not developed.
A comparison of our data across patient groups reveals
that the addition of myolysis to endometrial ablation
increases the rate of postsurgical amenorrhea from 36.5%
to 57% and reduces the rate of continued heavy bleeding
from 38% to 6.8%. (Table 2). Second procedures includ-
ing hysterectomies were reduced from 38% to 12.5%, and
the hysterectomy rate was reduced from 9.6% to under
5.7% by the combination of myolysis and ablation versus
ablation alone. In patients who underwent resection and
myolysis, rates of repeat procedures and hysterectomies
were 21% and 3.5%, respectively.
Although the ablation as a single procedure was per-
formed several years earlier than the combination surgi-
cal procedures, patients appeared to be fairly well
matched with regards to demographic variables. It
should be noted that a variety of techniques was used in
performing ablation and that two different techniques
were used in performing myoma coagulation. In addi-
tion, duration of follow-up varied across the three patient
groups. Volumetric data were not collected on the earli-
est patient group (those who received ablation alone), so
comparison of reduction of fibroid volumes across pro-
cedures is not possible. It is also not clear to what extent
the reductions in fibroid volume seen in the combina-
tion-procedure groups were attributable to the surgery
versus the administration of the GnRH agonist.
The literature has shown subsequent regrowth of
myomas once GnRH agonist-therapy concluded; there-
fore, the long-term size reduction attributed to agonist
therapy followed by myolysis and ablation can be
accepted as real.
This article represents the author's experience with sev-
eral recently developed surgical techniques that are suc-
cessful in relieving symptoms related to leiomyomas and
menorrhagia while leaving the uterus in place and reduc-
ing recovery time.
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Physicians should note that myolysis performed on an
extremely enlarged uterus (fibroids >10 cm or 14 week
gestation) is unlikely to succeed. Similarly, myolysis is
unlikely to have a satisfactory outcome in women with
disseminated leiomyomatosis. Endometrial ablation
alone should be reserved for those women with persis-
tent abnormal bleeding refractory to medical therapy
without significant fibroids or adenomyosis; submucosal
and intrauterine myomas must be identified and resected.
The addition of myolysis in patients with fibroid tumors
to endometrial ablation or resection markedly improves
the success rate of these minimally invasive alternatives
to hysterectomy.
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